Varinot et al. described strong HOXB13 immunostaining in all 400 analyzed prostate cancers and in secretory cells from all analyzed 120 normal prostates [13], while in another study, moderate to strong HOXB13 expression was found in only 30% of 44 prostate cancers [12]. This evidence concerns the gene HOXB13 and prostate carcinoma.